LINC00239 and colorectal carcinoma: Colorectal cancer (CRC): Increased expression of LINC00239 is associated with poorer prognosis in patients with CRC.138 Overexpression of LINC00239 inhibits erastin- and RSL3-mediated antitumor activity by inhibiting ferroptosis.